Answers are grounded in this paper and cite their sources.
Background: Diabetic Retinopathy (DR) is a significant complication of diabetes mellitus, which can worsen during rapid fluctuations in glycaemic control.Bariatric surgery can cause sudden improvement in diabetes control which can affect DR in the short term.Objectives: To assess the immediate and late impact of bariatric surgery on DR status in patients with type 2 diabetes mellitus and to evaluate the need for continuing retinal screening despite improvement or remission of diabetes.Methods: A retrospective clinical observational analysis was conducted on patients who underwent bariatric surgery for type 2 diabetes.One-year pre-operative and all post-operative retinal screen images were obtained and graded using the national diabetic eye screen programme grading.Patients were categorised into three groups: No-DR, B-DR (Background DR), Ref-DR (Referable DR).Pre-operative retinal images were compared against one-year post-operative and final retinal assessment imaging.Results: Data on 72 patients who fulfilled inclusion criteria was analysed.Mean duration of follow-up was 3.2(1-8) years.At baseline, 45 patients had No-DR (62.5%); 24 patients had B-DR (33%); 3 patients had Ref-DR (4.2%).At final assessment, 43 patients had No-DR (59.7%); 23 patients had B-DR (31.9%); 6 patients had Ref-DR (8.3%).Drop in HbA 1c at 1 year was a significantly higher in progressors (29.5 ± 12.1 vs. 19.2± 15.2 mmol/mol; P=0.038).On logistic regression (overall model chi-square=37.6) the HbA 1c drop at 1 year was a significant predictor for final progression in DR (wald=6.49;B=3.6±1.7;P=0.040) when corrected for demographics and baseline characteristics.; 6 patients progressed from No-DR to BDR at 1 year, whilst 7 progressed from No-DR to B-DR at the final assessment.Two patients progressed from B-DR to Ref-DR at 1 year, whilst 1 progressed from B-DR to Ref-DR at final assessment. Conclusion:Our study demonstrates the variable nature of progression of DR after bariatric surgery in patients with type 2 diabetes mellitus.Long term trials are needed to identify the pattern of progression and to identify risk factors.
No takes yet. Share an insight, caveat, or question.
Varadhan et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: